High-mobility group 1 protein inhibits helicase catalyzed displacement of cisplatin-damaged DNA. (Q38340847)

2 September 2017

title

High-mobility group 1 protein inhibits helicase catalyzed displacement of cisplatin-damaged DNA. (English)

1 reference

2 September 2017

S M Patrick

1 reference

2 September 2017

K M Henkels

series ordinal

1 reference

2 September 2017

J J Turchi

series ordinal

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

Biochimica et Biophysica Acta

2 September 2017

published in

1 reference

2 September 2017

volume

1354

1 reference

2 September 2017

1 reference

2 September 2017

page(s)

279-290

1 reference

Mechanisms of resistance to cisplatin

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

DNA excision-repair synthesis is enhanced in a murine leukemia L1210 cell line resistant to cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Cisplatin-DNA binding specificity of calf high-mobility group 1 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

DNA substrate specificity of DNA helicase E from calf thymus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

DNA helicase E and DNA polymerase epsilon functionally interact for displacement synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Effects of the anticancer drug cis-diamminedichloroplatinum(II) on the activities of calf thymus DNA polymerase epsilon

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Interaction between Cisplatin-modified DNA and the HMG Boxes of HMG 1: DNase I Footprinting and Circular Dichroism

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

DNase I footprinting of cis- or trans-diamminedichloroplatinum(II)-modified DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Intracellular distribution of HMG1, HMG2 and UBF change following treatment with cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Repair of cisplatin--DNA adducts by the mammalian excision nuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Repair of cisplatin-DNA adducts by protein extracts from human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

The XPA protein is a zinc metalloprotein with an ability to recognize various kinds of DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Preferential binding of the xeroderma pigmentosum group A complementing protein to damaged DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Mammalian DNA nucleotide excision repair reconstituted with purified protein components.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Xeroderma pigmentosum group E binding factor recognizes a broad spectrum of DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

Functional complementation of xeroderma pigmentosum complementation group E by replication protein A in an in vitro system

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900136-X

7 January 2021

10.1016/S0167-4781(97)00136-X

Identifiers

DOI

1 reference

2 September 2017

1 reference